Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
Study evaluates benefits of HBO2 therapy on post-concussion symptoms in military personnel with TBI

Study evaluates benefits of HBO2 therapy on post-concussion symptoms in military personnel with TBI

Close monitoring needed in year after traumatic brain injury

Close monitoring needed in year after traumatic brain injury

Longer looks: People with mental disabilities have a vote; Genome sequencing raises hope - also anxiety

Longer looks: People with mental disabilities have a vote; Genome sequencing raises hope - also anxiety

Teleconcussion for diagnosis and management of mild TBI in athletes

Teleconcussion for diagnosis and management of mild TBI in athletes

Mayo Clinic and collaborators to test new ways to provide specialized TBI care

Mayo Clinic and collaborators to test new ways to provide specialized TBI care

Comprehensive review article on baroreflex sensitivity after SCI

Comprehensive review article on baroreflex sensitivity after SCI

Ischemic stroke: an interview with Dr Gregory Ford

Ischemic stroke: an interview with Dr Gregory Ford

Single dose of etanercept can improve chronic neurological dysfunction from stroke or TBI

Single dose of etanercept can improve chronic neurological dysfunction from stroke or TBI

Telephone-based tinnitus-management program shows promise

Telephone-based tinnitus-management program shows promise

Baylor Institute for Rehabilitation receives $2.2 million grant

Baylor Institute for Rehabilitation receives $2.2 million grant

SUNY Downstate to join Neurological Emergencies Treatment Trials network

SUNY Downstate to join Neurological Emergencies Treatment Trials network

Intensive glycemic control does not reduce mortality in neurocritical care patients

Intensive glycemic control does not reduce mortality in neurocritical care patients

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

Brain Injury Research Center of Mount Sinai receives fund to research on TBI

New book aims to improve treatment and outcomes for people with head and neck injuries

New book aims to improve treatment and outcomes for people with head and neck injuries

Study assesses ethnic disparities among construction workers with injuries

Study assesses ethnic disparities among construction workers with injuries

Retinal imaging holds clues to cause of brain injury in children

Retinal imaging holds clues to cause of brain injury in children

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Amarantus acquires option to license LymPro Alzheimer's diagnostic blood test from MDx

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Navigating the Labyrinth of Traumatic Brain Injury to Discover a Secondary Neurological Condition

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.